This study characterized the plasma lipoproteins of familial hyperalphalipoproteinemic patients with or without deficiency of cholesteryl ester transfer protein (CETP) activity. The subjects with CETP deficiency have increased levels of apolipoprotein (apo) E. The increased concentration of apo E in these subjects was correlated to the appearance of apo E-rich high density lipoproteins (HDL). Sodium dodecyl sulfate-polyacrylamide gel analysis revealed that these lipoproteins contained predominantly the apo E (82%) and little amount of apo A-I (18%). These apo E-rich HDL displayed a much higher affinity than human LDL in binding to LDL receptors on human fibroblasts. Furthermore, 3.5 times fewer apo E-rich HDL than LDL were required to saturate the receptors on fibroblasts. These data indicated that the apo E-rich HDL in CETP-deficient human subjects contained multiple copies of apo E and bound to the LDL receptor through multiple interactions. The apo E-rich HDL, with similar properties as cholesterol-induced apo E HDLC, were not detectable in normal human subjects or in hyperalphalipoproteinemic subjects with normal CETP activity. The apo E-containing HDL in the latter subjects were smaller and contained only small amounts of apo E (14%). The difference in apo E-containing HDL in these subjects suggests a correlation between CETP level and the appearance of apo E-rich HDL. (J. Clin. Invest. 1990. 86:688-695.) Key words: cholesterol ester transfer * protein* apolipoprotein E -hyperalphalipoproteinemia * HDL Introduction Epidemiological studies have demonstrated that elevated levels of high density lipoprotein (HDL)-cholesterol are negatively correlated to the incidence of coronary heart disease, suggesting a role for HDL in the prevention of atherosclerotic lesions (1). Although the precise mechanism by which HDL can be protective against atherosclerosis remains unknown, a current hypothesis favors a role for HDL in cholesterol efflux from peripheral tissues and in the transport of extrahepatic
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cholesterol to the liver for reprocessing and excretion (2) . Although many environmental and hormonal factors may contribute to the control of HDL levels, previous studies have also shown that HDL level may also be regulated by genetic factors (3) .
Familial hyperalphalipoproteinemia has been reported to be inherited as an autosomal dominant trait characterized by increased plasma HDL-cholesterol (3) . Although earlier studies have suggested that hyperalphalipoproteinemia is associated with a single major gene (3) , it is likely that this condition can be a result of several different genetic abnormalities. Taskinen et al. (4) reported that members of five different families with high HDL-cholesterol levels frequently demonstrated increased lipoprotein lipase activity. In this particular case, the increase in HDL level may be derived from accelerated catabolism oftriglyceride-rich lipoproteins. Matsuzawa et al. (5) and Yamashita et al. (6) reported two cases of hyperalphalipoproteinemia with massive corneal opacification, one of which was also accompanied by coronary heart disease. These two probands were shown to have a decreased activity of hepatic triglyceride lipase (6) . More recently, Yamashita et al. (7) reported that, in three different families, a high level of HDL was associated with a dramatic decrease in the activity of plasma cholesteryl ester transfer protein (CETP).' These results suggest that plasma HDL level may also be correlated to CETP activity. The relationship between HDL level and CETP activity remains to be elucidated.
The correlation of CETP and HDL was also noted by characterization of lipoproteins in various animal models (8) . It is interesting to note that animals with low levels of CETP also displayed high plasma HDL (8) . These animals possess a unique subclass of HDL, called HDLI, that contains apolipoprotein (apo) A-I and apo E and has a hydrated density of 1.02-1.063 g/ml (9) . When these animals were fed a cholesterol-rich diet, the HDL1 was found to be larger, containing more cholesteryl ester and apo E. These cholesterol-induced lipoproteins are termed HDLC (9) . Although apo E has been detected in HDL1-and HDL2-like particles isolated from human subjects (10) (11) (12) , the presence of apo E-enriched HDL, with properties similar to HDL, has not been reported previously in fasted human subjects. It is possible that high CETP level in human subjects precludes the formation of these lipoproteins. This Human subjects. Plasma was obtained from two unrelated hyperalphalipoproteinemic patients (cases 1 and 2) with complete deficiency in CETP activity. The clinical data of patient 1 have been reported previously (7) . Plasma was also obtained from two hyperalphalipoproteinemic subjects with normal CETP activity and from ten normolipidemic individuals for comparison. The levels of HDL-cholesterol, apo E, and CETP activity in the plasma of these subjects are shown in Table I .
Lipoprotein isolation and characterization. Blood samples were collected after an overnight fast into tubes containing EDTA. Protease inhibitors (100 kIU/ml of aprotinin and 1 mM benzamidine) were added to the samples immediately after collection. Total lipids and HDL-cholesterol were determined as described previously (5) . Plasma apo E concentration was measured by the single radial immunodiffusion method (13) and isoelectric focusing of the apolipoproteins in VLDL was performed as described (14) . Cell culture and binding assays. The LDL was radiolabeled with '25I using iodine monochloride and the apo E-containing HDL were iodinated by the Bolton-Hunter method as described (20) . In a typical experiment, normal human fibroblasts were plated in 35-mm Petri dishes at a density of 3.5 X 104 cells per dish. When the cell culture reached 75% confluency, the monolayers were washed three times with DME and were cultured for 48 h in medium containing 10% human lipoprotein-deficient serum. The binding assays were performed as described (20) . Competitive binding studies were performed at 40C on ice by the addition of DME containing 25 (22) .
Cholesteryl ester transfer activity. The activity ofCETP was assayed as described (7) (24) .
Results
Lipoprotein characterization. The clinical data presented in Table I clearly indicate that patients with CETP deficiency have higher plasma levels of apo E. Isoelectric focusing analysis revealed that the apo E in these subjects are the E3/3 phenotype (data not shown). The increased amount of apo E along with hyperalphalipoproteinemia in these subjects suggested that apo E-rich HDL may be present in the plasma of these individuals. In view of the possibility that apo E could be transferred from VLDL to HDL during ultracentrifugation, the distribution of apo E among the patients' lipoproteins was compared with that of normal individuals initially by gel permeation chromatography. The distribution of plasma cholesterol, apo A-I, apo B, and apo E in each fraction was also determined for comparison (Fig. 1) . Results indicated that the apo B-containing lipoproteins from CETP-containing and
CETP-deficient hyperalphalipoproteinemic subjects eluted from the column at a position similar to control LDL. The apo A-I-containing lipoproteins in CETP-deficient subjects were larger than those in subjects with normal CETP and in control subjects. In contrast, the elution profiles of apo E-containing lipoproteins were strikingly different between the various samples. Although apo E from normal subjects and CETP-containing hyperalphalipoproteinemic patients were found predominantly in the VLDL fraction, the apo E-containing lipoproteins of CETP-deficient patients eluted from the column between the LDL and HDL particles and were clearly separated from the VLDL fraction (Fig. 1) . The column elution profile of these apo E-containing lipoproteins was similar to C) (Fig. 2 A) . The slow a-migrating d = 1.019-1.063 g/ml lipoproteins were especially evident from the two patients with CETP deficiency and appeared in trace amount in the hyperalphalipoproteinemic subject with normal CETP activity. Although these lipoproteins were not evident in the subjects with normal CETP activity, further fractionation of the d = 1.019-1.063 g/ml fraction revealed the presence of both slow a-and f-migrating lipoproteins in these subjects. The former lipoproteins were not detected from normal subjects. The slow a-migrating lipoproteins in the hyperalphalipoproteinemic subjects were then separated from the A-migrating lipoproteins in this density fraction by Pevikon block electrophoresis before further characterization. The resulting lipoproteins appeared to be homogeneous and migrated as a single band with a slow a mobility on agarose gels (Fig. 2 B) .
The a-and fl-migrating lipoproteins in the d = 1.019-1.063 g/ml fraction of the hyperalphalipoproteinemic subjects were further characterized by compositional analysis. Results indicated that the f-migrating lipoproteins contained more triglyceride and less cholesteryl ester than the normal LDL. The a-migrating lipoproteins were cholesteryl ester-rich and were depleted of triglyceride (Table III) . Moreover, SDS-PAGE of the apolipoproteins showed that the fi-lipoproteins were LDL and contained apo B 100 as the only apolipoprotein constituent (data not shown). In contrast, the a-lipoproteins contained apo E and apo A-I without any detectable apo B (Fig. 3) . It is interesting to note that the a-lipoproteins isolated from the subjects with CETP deficiency contained predominantly apo E. Based on densitometric scanning of the Coomassie Blue-stained gels, 82% of the apolipoproteins in this fraction was apo E and 18% was apo A-I. Therefore, the lipoproteins in this fraction displayed a composition similar to those of HDLC in hypercholesterolemic animals (9) . In contrast to the results of the CETP-deficient hyperalphalipoproteinemic subjects, the a-lipoproteins in the subjects with normal CETP resembled the HDLI and contained mostly apo A-I (-86%) with small amount (14%) of apo E. The apo Eenriched HDL detected in the plasma of CETP-deficient hyperalphalipoproteinemic subjects accounted for 6-10% of the total HDL cholesterol in these subjects. In contrast, the HDLI-like particles accounted for 2-3% of HDL cholesterol in patients with normal CETP (Table II) .
Receptor binding characteristics of the apo E-rich HDL. The demonstration of the apo E-rich HDL in CETP-deficient A) Before Pevikon Block B) After Pevikon Block Aeg/ml of LDL. Similar inhibition was observed with 9.0 ,g/ml of the apo E-containing HDL from the CETP-containing hyperalphalipoproteinemic patients. In contrast, the apo E-rich HDL, isolated from the CETP-deficient subjects, bound avidly to the LDL receptor on fibroblasts and inhibited 50% of 12511 LDL binding at concentrations of 0.25 and 0.30 ,gg/ml (data not shown).
The interaction of the different lipoproteins with the LDL receptor was further investigated by direct binding experiments using radiolabeled lipoproteins. The apo E-rich HDL from cases 1 and 2 were shown to have the highest affinity for the LDL receptor and bound to the fibroblasts with a Kd of 0.32 and 0.40 ,ug/ml, respectively (Fig. 4) . In contrast, normal LDL and apo E-containing HDL from normal CETP subjects bound to the fibroblasts with much lower affinity (Kd = 2.6 and 5.5 ,ug/ml, respectively). Interestingly, at receptor satura- tion, approximately equal number of LDL and apo E-containing HDL were bound to the cells. In contrast, 3.5-fold less apo E-rich HDL, from CETP-deficient subjects, were required for saturation of the LDL receptor on fibroblasts. These results indicated that the apo E-containing HDL from subjects with normal CETP were similar to LDL and interacted with the LDL receptor with a 1:1 stoichiometry (21). The higher affinity and lower capacity of the apo E-rich HDL from CETP-deficient subjects for the LDL receptor suggested that these lipoproteins may be similar to the HDLc in hypercholesterolemic animals and interacted with the LDL receptor through multiple receptor binding domains (21).
Discussion
The current study indicates that there are at least two types of hyperalphalipoproteinemia. One of these may be related to defective CETP activity and the appearance of large apo Erich HDL. The second form of hyperalphalipoproteinemia may be related to increased number of HDL,-and HDL2-like (22, 26) . Therefore, the apo E-containing HDL in human subjects described thus far were similar to HDL1 and HDL2, and were quite different from the cholesteryl ester-rich and apo E-rich HDLC. The latter lipoproteins have been shown to display a much higher affinity than LDL in binding to the LDL receptor (22) . Since apo E-rich HDLC was only detected in animals with low CETP level after cholesterol feeding, it is possible that the high level of CETP in human subjects may inhibit the formation of these apo E-rich HDL. The results of the current study, showing the accumulation of apo E-rich HDL in CETP-deficient human subjects, are supportive ofthis hypothesis. The human apo E-rich HDL reported in this study was observed as a prominent lipoprotein in familial hyperalphalipoproteinemic subjects with deficiency ofCETP. The apo E-rich HDL was not observed in the plasma of hyperalphalipoproteinemic subjects with normal CETP activity. The presence ofthe unique apo E-rich HDL in CETP-deficient subjects is most likely a direct result of defective cholesteryl ester transfer from 'HDL to VLDL. An inverse relationship between CETP and the accumulation of large HDL was suggested previously in animal studies and in in vitro experiments. Gavish et al. (27) showed that the conversion of HDL3 to large HDL in the rat could be delayed by infusion of partially purified CETP. In more recent studies by Tall and his associates (28, 29), inhibition of CETP activity in vitro with a neutralizing antibody resulted in the redistribution ofapo E to larger lipoproteins and the inhibition of cholesteryl ester transfer from HDL to VLDL. The observation that apo Eenriched HDLC was found only in cholesterol-fed animals which have low levels of CETP activity (9) is supportive ofthis hypothesis.
The apo E-rich, cholesteryl ester-rich HDL was also detected in neonates (30) and in abetalipoproteinemic patients (31, 32) . Although the level of CETP in these subjects was unknown, it is interesting to note that the plasma of neonates contained only small amounts of VLDL (33) . The abetalipoproteinemic subjects also contained little, if any, VLDL owing to defects in the synthesis oftriglyceride-rich lipoproteins. The accumulation of apo E-rich lipoproteins in these subjects was probably due to the absence of an acceptor lipoprotein for the cholesteryl ester transfer pathway (31) . In the current study, we showed directly that CETP deficiency resulted in the accumulation ofthe cholesteryl ester-rich HDL with an enrichment of apo E. The increased core volume of the HDL, owing to continuous acquisition and esterification of cholesterol, required the continuous addition of apo E (34) . The accumulation of these apo E-rich and cholesteryl ester-rich HDL in CETP-deficient subjects must then be due to the inability to transfer excess cholesteryl ester and possibly apo E to lower density lipoproteins. Additionally, the accumulation of these apo Erich lipoproteins, which have a high affinity for the LDL receptor, suggests that the accumulation of apo E-rich and cholesteryl ester-rich HDL results in a slower catabolic rate due to saturation of the hepatic LDL receptor.
The results of this study, together with those of other investigators, suggested that low CETP level may increase cholesteryl ester-rich HDL concentrations in plasma. A corollary to this observation would be the increased formation of cholesteryl ester-rich VLDL in the presence of high CETP level. Since cholesteryl ester-rich VLDL have been shown to induce cholesteryl ester accumulation and foam cell formation in macrophages (2, 34, 35) , a high CETP level may indirectly contribute to the atherogenic process. Future clinical studies in patients with known premature vascular disease would be valuable in order to assess the validity of this theory.
